U.S. flag

An official website of the United States government, Department of Justice.

Medication Assisted Treatment - Prescription Drug and Opioid Addiction

Author(s)
SAMHSA
Date Published
May 2017
Publication Series
Description

The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT), is accepting applications for fiscal year (FY) 2017 Targeted Capacity Expansion: Medication Assisted Treatment - Prescription Drug and Opioid Addiction (MAT-PDOA) grants. The purpose of this program is to expand/enhance access to medication-assisted treatment (MAT) services for persons with an opioid use disorder seeking or receiving MAT. This program targets states identified with having the highest rates of primary treatment admissions for heroin and opioids per capita and includes those states with the most dramatic increases for heroin and opioids, based on SAMHSA’s Treatment Episode Data Set (TEDS): 2007 – 2014. The desired outcomes include:

  1. An increase in the number of admissions for MAT;
  2. An increase in the number of clients receiving integrated care/treatment;
  3. A decrease in illicit opioid drug use at six-month follow-up; and
  4. A decrease in the use of prescription opioids in a non-prescribed manner at six-month follow-up.

Applications are due Monday, July 31, 2017. For more information, please click here

Date Published: May 1, 2017